Saturday, February 8, 2014

Biotechnology Industry Organization (BIO) Comments on the “Draft Guidance for Industry on Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act.”

No comments: